Literature DB >> 6642292

Ticlopidine: a promise for the prevention and treatment of thrombosis and its complications.

E Panak, J P Maffrand, C Picard-Fraire, E Vallée, J Blanchard, R Roncucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6642292     DOI： 10.1159/000214831

Source DB:  PubMed          Journal:  Haemostasis        ISSN： 0301-0147


× No keyword cloud information.
  15 in total

1.  Pharmacodynamics of ticlopidine in man in relation to plasma and blood cell concentration.

Authors:  T DiPerri; F L Pasini; C Frigerio; P Blardi; F Centini; G L Messa; A Ghezzi; L Volpi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders.

Authors:  D McTavish; D Faulds; K L Goa
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

Review 3.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

Review 4.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

5.  Single and multiple dose pharmacokinetics of ticlopidine in young and elderly subjects.

Authors:  J Shah; P Teitelbaum; B Molony; T Gabuzda; I Massey
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

Review 6.  Pharmacokinetic optimisation of the treatment of embolic disorders.

Authors:  D M Lutomski; M Bottorff; K Sangha
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

Review 7.  Plant extracts inhibit ADP-induced platelet activation in humans: their potential therapeutic role as ADP antagonists.

Authors:  Indera Anita Jagroop
Journal:  Purinergic Signal       Date:  2013-11-05       Impact factor: 3.765

Review 8.  Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke.

Authors:  Thomas Lenz; Amy Wilson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 9.  Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states.

Authors:  E Saltiel; A Ward
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

Review 10.  Clinical pharmacokinetics of ticlopidine.

Authors:  J P Desager
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.